From: Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis
Variable | Total | Death | Survival | p | OR (95%CI) |
---|---|---|---|---|---|
Age (years old): | 94 | 0.570 | 1.510 (0.364, 6.256) | ||
< 40; | 7; | 51; | |||
≥ 40 | 3 | 33 | |||
Gender: | 94 | 0.259 | 3.393 (0.407, 28.297) | ||
Male; | 9; | 61; | |||
Female | 1 | 23 | |||
Fever: | 94 | 0.123 | 0.109 (0.636, 43.550) | ||
Yes; | 1; | 31; | |||
No | 9 | 53 | |||
Dizziness: | 94 | 0.136 | 0.500 (0.604, 41.392) | ||
Yes; | 1; | 30; | |||
No | 9 | 54 | |||
Headache: | 94 | 0.776 | 1.230 (0.296, 5.117) | ||
No; | 3; | 29; | |||
Yes | 7 | 55 | |||
Vomiting: | 94 | 0.732 | 1.286 (0.305, 5.426) | ||
No; | 7; | 63; | |||
Yes | 3 | 21 | |||
Memory deficits: | 94 | 0.030 | 4.500 (1.157, 17.500) | ||
No; | 4; | 63; | |||
Yes | 6 | 21 | |||
Cognitive impairment: | 94 | 0.133 | 3.950 (0.657, 23.749) | ||
No; | 8; | 79; | |||
Yes | 2 | 5 | |||
Disorders of consciousness: | 94 | 0.005 | 7.400 (1.817, 30.144) | ||
No; | 5; | 74; | |||
Yes | 5 | 10 | |||
Dysphasia: | 94 | 0.008 | 6.375 (1.608, 25.274) | ||
No; | 4; | 68; | |||
Yes | 6 | 16 | |||
Meningeal irritation signs: | 94 | 0.053 | 6.750 (0.979, 46.551) | ||
No; | 8; | 81; | |||
Yes | 2 | 3 | |||
Time from symptom onset to presentation: | 94 | 0.193 | 2.567 (0.621, 10.604) | ||
< 15 days; | 3; | 44; | |||
≥15 days | 7 | 40 | |||
ART initiation: | 94 | 0.421 | 1.731 (0.455, 6.582) | ||
No; | 4; | 45; | |||
Yes | 6 | 39 | |||
CD4+ T-cell counts: | 94 | 0.005 | 7.982 (1.880, 33.890) | ||
≥ 25 cells/μL; | 3; | 65; | |||
< 25 cells/μL | 7 | 19 | |||
Patchy lesions on MRI: | 94 | 0.192 | 2.437 (0.639, 9.305) | ||
No; | 4; | 52; | |||
Yes | 6 | 32 | |||
Ring-enhancing lesions on MRI: | 94 | 0.790 | 0.833 (0.218, 3.188) | ||
No; | 4; | 30; | |||
Yes | 6 | 54 |